scholarly article | Q13442814 |
P50 | author | Chris J L M Meijer | Q90379336 |
Peter J F Snijders | Q90768556 | ||
P2093 | author name string | Theo J M Helmerhorst | |
Johannes Berkhof | |||
René H M Verheijen | |||
Veerle M H Coupé | |||
Murat Gök | |||
Cornelis J A Hogewoning | |||
P2860 | cites work | Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. | Q54739380 |
Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri | Q73538537 | ||
Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study | Q78001750 | ||
HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3 | Q79124299 | ||
Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence | Q81195427 | ||
Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial | Q28210999 | ||
A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix | Q31987917 | ||
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes | Q33950978 | ||
The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. | Q35587534 | ||
HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis | Q35806249 | ||
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands | Q36613522 | ||
Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia | Q36622802 | ||
The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix | Q38449923 | ||
Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse | Q40421829 | ||
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities | Q44113435 | ||
Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens | Q44830999 | ||
Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study | Q47668351 | ||
Natural history of cervicovaginal papillomavirus infection in young women. | Q50909200 | ||
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. | Q51968734 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 273-275 | |
P577 | publication date | 2006-12-08 | |
P1433 | published in | Gynecologic Oncology | Q5625182 |
P1476 | title | HPV16 and increased risk of recurrence after treatment for CIN. | |
P478 | volume | 104 |
Q33955735 | Absence of dysplasia in the excised cervix by a loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia. |
Q37025594 | Cervical cancer prevention--cervical screening: science in evolution |
Q43890162 | DNA nanotherapy for pre-neoplastic cervical lesions |
Q36313262 | Early human papillomavirus testing predicts residual/recurrent disease after LEEP. |
Q37248557 | Factors associated with HPV persistence after conization in patients with negative margins |
Q36739942 | Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management |
Q80977506 | HPV testing in the follow-up after treatment of women with CIN |
Q36071760 | HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice |
Q90035185 | HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control |
Q26771420 | HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions |
Q80744623 | HPV16 and increased risk of recurrence after treatment for CIN |
Q84147482 | How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands |
Q92561088 | Human Papillomavirus Genotyping Compared With a Qualitative High-Risk Human Papillomavirus Test After Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Systematic Review |
Q35768850 | Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: A Retrospective Monoinstitutional Cohort Study |
Q85092805 | Predictors of recurrence in high-grade cervical lesions and a plan of management |
Q36791086 | Primary extraosseous Ewing sarcoma of the lung in children |
Q42209411 | Prognostic scores after surgical treatment for cervical intraepithelial neoplasia: a proposed model and possible implications for post-operative follow-up |
Q33940220 | Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors |
Q38661394 | Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia |
Q37018994 | The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening |
Q41644498 | The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS. |
Q54402491 | Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation. |
Q42217979 | Unique recurrence patterns of cervical intraepithelial neoplasia after excision of the squamocolumnar junction. |
Search more.